Measuring rater bias in diagnostic tests with ordinal ratings.

Abstract

Diagnostic tests are frequently reliant upon the interpretation of images by skilled raters. In many clinical settings, however, the variability observed between experts' ratings plays a detrimental role in the degree of confidence in these interpretations, leading to uncertainty in the diagnostic process. For example, in breast cancer testing, radiologists interpret mammographic images, while breast biopsy results are examined by pathologists. Each of these procedures involves elements of subjectivity. We propose here a flexible two-stage Bayesian latent variable model to investigate how the skills of individual raters impact the diagnostic accuracy of image-related testing in large-scale medical testing studies. A strength of the proposed model is that the true disease status of a patient within a reasonable time frame may or may not be known. In these studies, many raters each contribute classifications on a large sample of patients using a defined ordinal grading scale, leading to a complex correlation structure between ratings. Our modeling approach considers the different sources of variability contributed by experts and patients while accounting for correlations present between ratings and patients, in contrast to currently available methods. We propose a novel measure of a rater's ability (magnifier) that, in contrast to conventional measures of sensitivity and specificity, is robust to the underlying prevalence of disease in the population, providing an alternative measure of diagnostic accuracy across patient populations. Extensive simulation studies demonstrate lower bias in estimation of parameters and measures of accuracy, and illustrate outperformance of the proposed model when compared with existing models. Receiver operator characteristic curves are derived to assess the diagnostic accuracy of individual experts and their overall performance. Our proposed modeling approach is applied to a large breast imaging study for known disease status and a uterine cancer dataset for unknown disease status.